Takanashi Y - Search Results

1

Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Noguchi Y, Takanashi Y. Yukawa N, et al. Among authors: takanashi y. Br J Surg. 2001 Dec;88(12):1596-601. doi: 10.1046/j.0007-1323.2001.01930.x. Br J Surg. 2001. PMID: 11736971

2

Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma.

Morinaga S, Yamamoto Y, Noguchi Y, Imada T, Rino Y, Akaike M, Sugimasa Y, Takemiya S, Kameda Y, Takanashi Y. Morinaga S, et al. Among authors: takanashi y. J Gastroenterol Hepatol. 2002 Oct;17(10):1110-6. doi: 10.1046/j.1440-1746.2002.02836.x. J Gastroenterol Hepatol. 2002. PMID: 12201873

3

Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver.

Morinaga S, Yamamoto Y, Noguchi Y, Imada T, Rino Y, Akaike M, Sugimasa Y, Takemiya S, Takanashi Y. Morinaga S, et al. Among authors: takanashi y. Hepatogastroenterology. 2003 Sep-Oct;50(53):1521-6. Hepatogastroenterology. 2003. PMID: 14571777

4

Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.

Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S. Morinaga S, et al. Among authors: takanashi y. Oncol Rep. 2004 Dec;12(6):1189-94. Oncol Rep. 2004. PMID: 15547736

5

Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.

Morinaga S, Ishiwa N, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S. Morinaga S, et al. Among authors: takanashi y. J Surg Oncol. 2005 Dec 15;92(4):331-6. doi: 10.1002/jso.20309. J Surg Oncol. 2005. PMID: 16299800

6

Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry.

Morinaga S, Imada T, Shimizu A, Akaike M, Sugimasa Y, Takemiya S, Takanashi Y. Morinaga S, et al. Among authors: takanashi y. Hepatogastroenterology. 2001 Jan-Feb;48(37):224-8. Hepatogastroenterology. 2001. PMID: 11268971

7

Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.

Okamoto T, Tsuburaya A, Yanoma S, Yoshikawa T, Cho H, Takanashi Y, Noguchi Y. Okamoto T, et al. Among authors: takanashi y. Anticancer Res. 2003 Jan-Feb;23(1A):149-53. Anticancer Res. 2003. PMID: 12680206

8

High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract.

Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, Takanashi Y, Ito T, Tsuburaya A. Fukuzawa K, et al. Among authors: takanashi y. Cancer Lett. 1999 Oct 1;144(2):145-51. doi: 10.1016/s0304-3835(99)00223-2. Cancer Lett. 1999. PMID: 10529014

9

Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice.

Yamada R, Yanoma S, Akaike M, Tsuburaya A, Sugimasa Y, Takemiya S, Motohashi H, Rino Y, Takanashi Y, Imada T. Yamada R, et al. Among authors: takanashi y. Cancer Lett. 2006 Aug 8;239(2):190-7. doi: 10.1016/j.canlet.2005.08.002. Epub 2005 Sep 19. Cancer Lett. 2006. PMID: 16171944

10

Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.

Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Manabe T, et al. Among authors: takanashi y. Surg Today. 2004;34(3):220-5. doi: 10.1007/s00595-003-2683-3. Surg Today. 2004. PMID: 14999533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters